13479-38-4 Usage
Uses
Used in Pharmaceutical Industry:
(11beta)-11,21-dihydroxypregna-1,4-diene-3,20-dione is used as an anti-inflammatory and immunosuppressive agent for the treatment of various medical conditions, such as inflammation, allergic reactions, and certain types of cancer. Its potent anti-inflammatory effects help alleviate symptoms and improve overall health.
Used in Inflammatory Conditions:
(11beta)-11,21-dihydroxypregna-1,4-diene-3,20-dione is used as a medication to reduce inflammation in various conditions, such as rheumatoid arthritis, lupus, and asthma. Its ability to suppress the immune system helps control the body's inflammatory response and provide relief from symptoms.
Used in Allergic Reactions:
(11beta)-11,21-dihydroxypregna-1,4-diene-3,20-dione is used as an anti-allergic medication to treat severe allergic reactions and conditions, such as anaphylaxis and severe asthma. Its immunosuppressive properties help reduce the body's allergic response and provide relief from symptoms.
Used in Cancer Treatment:
(11beta)-11,21-dihydroxypregna-1,4-diene-3,20-dione is used as a medication in the treatment of certain types of cancer, such as brain tumors and leukemia. Its anti-inflammatory and immunosuppressive effects can help manage symptoms and improve the effectiveness of other cancer treatments.
Used in Ophthalmology:
(11beta)-11,21-dihydroxypregna-1,4-diene-3,20-dione is used as an eye drop to treat eye inflammation and conditions such as uveitis and iritis. Its anti-inflammatory properties help reduce inflammation and alleviate symptoms in the eye.
Check Digit Verification of cas no
The CAS Registry Mumber 13479-38-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,4,7 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13479-38:
(7*1)+(6*3)+(5*4)+(4*7)+(3*9)+(2*3)+(1*8)=114
114 % 10 = 4
So 13479-38-4 is a valid CAS Registry Number.
13479-38-4Relevant articles and documents
Cytotoxic nucleoside-corticosteroid phosphodiesters
-
, (2008/06/13)
Nucleotides of nucleosides or bases having known cytotoxic activity are reacted with steroids, preferably corticosteroids, to form corresponding cytotoxic nucleoside-corticosteroid phosphodiester analogues of the formula: STR1 wherein: steroid is the residue formed by removal of a hydroxyl hydrogen atom from a natural or synthetic adrenal corticosteroid containing the characteristic cyclopentanophenanthrene nucleus which is esterified to the phosphate moiety at the 21-position; sugar is a naturally occurring pentose or deoxypentose in the furanose form, preferably ribose, deoxyribose, lyxose, xylose or arabinose and especially ribose, deoxyribose or arabinose, which is esterified to the phosphate moiety at the 5'-position and covalently bonded to the heterocycle moiety at the 1'-position to form a nucleoside; and heterocycle is a purine, pyrimidine, hydrogenated pyrimidine, triazolopurine or similar nucleoside base. The conjugates exhibit an enhanced therapeutic index as compared to the parent nucleoside or base compounds, and are thus useful cytotoxic, antiviral and antineoplastic agents.